Results 101 to 110 of about 411,749 (186)

Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK. [PDF]

BMJ Open Diabetes Res Care, 2019
Thalange N, Gundgaard J, Parekh W, Tutkunkardas D.   +3 more
europepmc   +1 more source

Comparison of the Efficacy and Safety of Insulin Detemir Administered Once Daily According to Two Titration Algorithms (3-0-3 and 2-4-6-8) in Patients with Type 2 Diabetes Mellitus. [PDF]

Endocrinol Metab (Seoul), 2020
Yu HM, Park KS, Hong JH, Park KY, Lee JM, Ku BJ, Kim YJ, Oh TK.   +7 more
europepmc   +1 more source

Differences in Effect of Insulin Detemir and NPH Insulin on Glucose and Lipid Metabolism.

, 2004
Insulin detemir has a 14C fatty acid chain, which associates with free fatty acid binding sites on albumin. Capillary endothelial cells in adipose tissue and muscle may limit transfer of insulin detemir from the circulation into the extravascular ...
Hodern, Sara Victoria Margaret.
core  

Reduced Efficacy of Insulin Detemir in Controlling Hyperglycemia during Pregnancy: An Interesting Case Report. [PDF]

Indian J Endocrinol Metab, 2018
Pande A, Aggarwal A, Wadhwa R.
europepmc   +1 more source

A short-course of low-dose insulin detemir effectively decreases blood glucose levels in gestational diabetic women undergoing dexamethasone treatment to promote newborn lung maturity. [PDF]

Medicine (Baltimore)
Wu WZ, Huang FY, Li SY, Wang Y, Chen J, Zeng LZ, Li YT.   +6 more
europepmc   +1 more source

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol. [PDF]

Pharmacy (Basel), 2017
Davis S, Friece C, Roderman N, Newcomer D, Castaneda E.   +4 more
europepmc   +1 more source

A 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2). [PDF]

Eur J Pediatr, 2018
Wheeler MD, Barrientos-Perez M, Lo FS, Liang B, Lunsford A, Thórisdóttir Ó, Zuckerman-Levin N.   +6 more
europepmc   +1 more source

Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2-16 Years. [PDF]

Diabetes Ther, 2016
Thalange N, Bereket A, Jensen LB, Hiort LC, Peterkova V.   +4 more
europepmc   +1 more source

The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials. [PDF]

Pediatr Diabetes, 2019
Thalange N, Deeb L, Klingensmith G, Franco DR, Bardtrum L, Tutkunkardas D, Danne T.   +6 more
europepmc   +1 more source

Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials. [PDF]

Diabetes Obes Metab
Amaral R, Costa B, Penedones A, Mendes D, Alves C.   +4 more
europepmc   +1 more source